JAMA study casts cloud over biologic safety.
Kling
Jim
J
D000911:Antibodies, Monoclonal / Q000737:chemistry; D001688:Biological Products / Q000009:adverse effects*; D001709:Biotechnology / Q000379:methods / Q000639:trends*; D002986:Clinical Trials as Topic; D004345:Drug Industry; D005060:Europe; D006801:Humans; D008297:Male; D012107:Research Design; D012449:Safety; D014481:United States; D014486:United States Food and Drug Administration
D000911:Antibodies, Monoclonal; D001688:Biological Products